XML 58 R35.htm IDEA: XBRL DOCUMENT v3.25.0.1
The Company (Details) - USD ($)
$ in Thousands
 1 Months Ended 12 Months Ended
Nov. 30, 2022
Dec. 31, 2024
Dec. 31, 2023
Dec. 31, 2025
Subsidiary, Sale of Stock [Line Items]        
Accumulated deficit   $ 530,950 $ 503,809  
Net cash used in operating activities   17,949 $ 19,701  
Cash, cash equivalents, and short-term investments   52,800    
Minimum annual net revenue   70,000    
Minimum cash and cash equivalents required after completion of IPO   $ 5,000    
Forecast        
Subsidiary, Sale of Stock [Line Items]        
Minimum cash and cash equivalents required after completion of IPO       $ 5,000
At-the-Market Equity Offering        
Subsidiary, Sale of Stock [Line Items]        
Proceeds from issuance of preferred stock, preference stock, and warrants $ 150,000      
Proceeds from issuance or sale by company of common stock $ 50,000      
Percentage of shares of common stock sold under sales agreement 3.00%      
Number of shares issued in transaction (in shares)   444,555 933,500  
Issuance of common stock   $ 3,400 $ 8,100  
Aggregate net proceeds   3,200 $ 7,600  
Amount remaining under ATM program   $ 38,500